DOI QR코드

DOI QR Code

Possible Mechanism Underlying the Antiherpetic Activity of a Proteoglycan Isolated from the Mycelia of Ganoderma lucidum in Vitro

  • Li, Zubing (School of Stomatology, Wuhan University) ;
  • Liu, Jing (School of Stomatology, Wuhan University) ;
  • Zhao, Yifang (School of Stomatology, Wuhan University)
  • Published : 2005.01.31

Abstract

GLPG (Ganoderma lucidum proteoglycan) was a bioactive fraction obtained by the liquid fermentation of the mycelia of Ganoderma lucidum, EtOH precipitation, and DEAE-cellulose column chromatography. GLPG was a proteoglycan with a carbohydrate: protein ratio of 10.4: 1. Its antiviral activities against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) were investigated using a cytopathic inhibition assay. GLPG inhibited cell death in a dose-dependent manner in HSV-infected cells. In addition, it had no cytotoxic effect even at 2 mg/ml. In order to study the mode of action of the antiviral activity of GLPG, cells were treated with GLPG before, during, and after infection, and viral titer in the supernatant of cell culture 48 h post-infection was determined using a $TCID_{50}$ assay. The antiviral effects of GLPG were more remarkable before viral treatment than after treatment. Although the precise mechanism has yet to be defined, our work suggests that GLPG inhibits viral replication by interfering with the early events of viral adsorption and entry into target cells. Thus, this proteoglycan appears to be a candidate anti-HSV agent.

Keywords

References

  1. Cinatl, J. Jr., Cinatl, J., Rabenau, H., Kornhuber, B. and Doerr, H. W. (1992) HeLa cells grown continuously in protein-free medium: A novel model for the study of virus replication. Intervirology 33, 41-48
  2. Cocchi, F., Lopez, M., Dubreuil, P., Campadelli Fiume, G. and Menotti, L. (2001) Chimeric nectin l-poliovirus receptor molecules identify a nectinl region functional in herpes simplex virus entry. J. Virology 75, 7987-7994 https://doi.org/10.1128/JVI.75.17.7987-7994.2001
  3. Coen, D. M. (1991) The implications of resistance to antiviral agents for herpes virus drug targets and drug therapy. Antiviral Res. 15, 287-300 https://doi.org/10.1016/0166-3542(91)90010-O
  4. Cook, M. L. and Stevens, J. G. (1973) Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. Infect. Immun. 7, 272-288
  5. Dubois, M., Gilles, K. A., Hamilton, J. K., Rebers, P. A. and Smith, F. (1956) Colorimetric method for the determination of sugars and related substances. Anal. Chem. 28, 350-356 https://doi.org/10.1021/ac60111a017
  6. Eo, S. K., Kim, Y. S., Lee, C. K. and Han, S. S. (1999) Antiherpetic activities of various protein bound polysaccharide isolated from Ganoderma lucidum. J. Ethnopharmacol. 68, 175-181 https://doi.org/10.1016/S0378-8741(99)00086-0
  7. Flint, S. J., Enquist, L. W., Krug, R. M., Racaniello, V. R. and Skalka, A. M. (2000) Virus Cultivation, Detection and Genetics; in Principles of Virology, pp. 32-33, ASM Press, Washington, USA
  8. Herold, B. C., WuDunn, D., Soltys, N. and Spear, P. G. (1991) Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virology 65, 1090-1098
  9. Hikino, H., Konno, C., Mirin, Y. and Hayashi, T. (1985) Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies. Planta Medica 51, 339-340 https://doi.org/10.1055/s-2007-969507
  10. Hook, E. W. III, Cannon, R. O. and Nahmias, A. J. (1992) Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J. Infect. Dis. 165, 251-255 https://doi.org/10.1093/infdis/165.2.251
  11. Kawagishi, H., Fukuhara, F., Sazuka, M., Kawashima, A., Mitsubori, T. and Tomita, T. (1993) 5-Deoxy-5-methylsulphinyladenosine, a platelet aggregation inhibitor from Ganoderma lucidum. Phytochem. 32, 239-241 https://doi.org/10.1016/S0031-9422(00)94974-4
  12. Kim, K. C. and Kim, I. G. (1999) Ganoderma lucidum extract protects DNA from strand breakage caused by hydroxyl radical and UV irradiation. Int. J. Mol. Med. 4, 273-277
  13. Kim, M. J., Kim, H. W., Lee, Y. S., Shim, M. J., Choi, E. C. and Kim, B. K. (1986) Studies on safety of Ganoderma lucidum. Korean J. Mycol. 14, 49-59
  14. Kim, Y. S., Eo, S. K., Oh, K. W., Lee, C. K. and Han, S. S. (2000) Antiherpetic activities of acidic protein bound polysaccharide isolated from Ganoderma lucidum alone and in combinations with interferons, J. Ethnopharmacol. 72, 451-458 https://doi.org/10.1016/S0378-8741(00)00263-4
  15. Lee, S. Y. and Rhee, H. M. (1990) Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action. Chem. Pharm. Bull. 38, 1359-1364 https://doi.org/10.1248/cpb.38.1359
  16. Lin, J. M., Lin, C. C., Chen, M. F., Ujiie, T. and Takana, A. (1995) Radical scavenger and antihepatotoxic of Ganoderma formasanum, Gamoderma lucidum and Ganoderma neojaponicum. J. Ethnopharmacol. 47, 33-41 https://doi.org/10.1016/0378-8741(95)01251-8
  17. Lin, S. B., Li, C. H., Lee, S. S. and Kan, L. S. (2003) Triterpeneenriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci. 72, 2381-2390 https://doi.org/10.1016/S0024-3205(03)00124-3
  18. Lin, Z. B. (1991) Pharmacological effects and clinical applications of Ganoderma lucidum.; in Recent Advances in Chinese Herbal DrugsActions and Uses, Zhou, J. H. and Liu, G. Z., (eds.), pp. 133-140, Beijing: Scientific Publishing House, China
  19. Lin, Z. B. (2001) Pharmacological effects of Ganoderma lucidum.; in Modern Research of Ganoderma Lucidum , Lin, Z. B. (ed.), pp. 219-283, Beijing Medical University Press, Beijing, China
  20. Lapucci, A., Macchia, M. and Parkin, A. (1993) Antiherpes virus agents: a review. IL Farmaco 48, 871-895
  21. Marchetti, M., Longhi, C., Conte, M. P., Pisani, S., Valenti, P. and Seganti, L. (1996) Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antiviral Res. 29, 221-231 https://doi.org/10.1016/0166-3542(95)00840-3
  22. Marchetti, M., Pisani, S., Pietropaolo, V., Seganti, L., Nicoletti, R. and Orsi, N. (1994) Inhibition of herpes simplex virus infection by negatively charged and neutral carbohydrate polymers. J. Chemotherapy 7, 9096
  23. Miyazaki, T. and Nishijima, M. (1981) Studies on fungal polysaccharides. XXVII. Structural examination of a watersoluble, antitumor polysaccharide of Ganoderma lucidum. Chem. Pharm. Bull. 29, 3611-3616 https://doi.org/10.1248/cpb.29.3611
  24. Mizuno, T., Nato, N., Totsuka, A., Takenaka, K., Shinkai, K. and Shimizu, M. (1984) Fractionation, structural features and antitumor activity of water soluble polysaccharide from Reishi, the fruit body of Ganoderma lucidum. Nippon Nogeikagaku kaishi 58, 871-880 https://doi.org/10.1271/nogeikagaku1924.58.871
  25. Mizuno, T., Wang, G., Zhang, J., Kawagishi, H., Nishitoba, T. and Li, J. (1995) Reishi Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects. Food Rev. Int. 11, 151-166 https://doi.org/10.1080/87559129509541025
  26. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63 https://doi.org/10.1016/0022-1759(83)90303-4
  27. Patick, A. K. and Potts, K. E. (1998) Protease inhibitors as antiviral agents. Clin. Microbiol. Rev. 11, 614-627
  28. Shieh, M. T., WuDunn, D., Montgomery, R. I., Esko, J. D. and Spear, P. G. (1992) Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116, 1273- 1281 https://doi.org/10.1083/jcb.116.5.1273
  29. Sugiura, M. and Ito, H. (1977) Toxicological studies of Ganoderma lucidum. Tokyo Yakka Daigaku Kenkyu Nenpo 27, 722-733
  30. Tang, Y. J. and Zhong, J. J. (2002) Fed-batch fermentation of Ganoderma lucidum for hyperproduction of polysaccharide and ganoderic acid. Enzyme Micro. Technol. 31, 20-28 https://doi.org/10.1016/S0141-0229(02)00066-2
  31. Townsend, J. J. and Collins, P. K. (1986) Peripheral nervous system demyelination with herpes simplex virus. J. Neuropathol. Exp. Neurol. 45, 419-425 https://doi.org/10.1097/00005072-198607000-00004
  32. Trybala, E., Bergstrom, T., Svennerholm, B., Jeansson, S., Glorioso, J. C. and Olofsson, S. (1994) Localization of a functional site on herpes simplex virus 1 glycoprotein C involved in binding to cell surface heparan sulphate. J. Gen. Virol. 75, 743-752 https://doi.org/10.1099/0022-1317-75-4-743
  33. Witvrouw, M., Desmyter, J. and De Clercq, E. (1994) Antiviral portrait series: 4. polysulfates as inhibitors of HIV and other enveloped viruses. Antiviral Chem. Chemother. 5, 345-359
  34. Woo, E. R., Kim, H. J., Kwak, J. H., Lim, Y. K., Park, S. K., Kim, H. S., Lee, C.-K. and Park, H. (1997) Anti-herpetic activity of various medicinal plant extracts. Arch. Pharm. Res. 20, 58-67 https://doi.org/10.1007/BF02974043
  35. Wudunn, D. and Spear, P. G. (1989) Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virology 63, 52-58
  36. Yang, F. C., Ke, Y. F. and Kuo, S. S. (2000) Effect of fatty acids on the mycelial growth and polysaccharide formation by Ganoderma lucidum in shake flask cultures. Enzyme Microb. Technol. 27, 295-301 https://doi.org/10.1016/S0141-0229(00)00213-1

Cited by

  1. Structural characterization and bioactivity evaluation of an acidic proteoglycan extract fromGanoderma lucidumfruiting bodies for PTP1B inhibition and anti-diabetes vol.101, pp.6, 2014, https://doi.org/10.1002/bip.22426
  2. Biological activity of glycopolymers from Basidiomycetes mushrooms vol.25, pp.3, 2009, https://doi.org/10.7124/bc.0007DB
  3. Current status of natural products from plants as anti-herpes simplex virus 1 agents vol.23, pp.5, 2008, https://doi.org/10.1007/s12250-008-2962-7
  4. Effects of extracellular polysaccharides of Ganoderma lucidum supplementation on the growth performance, blood profile, and meat quality in finisher pigs vol.178, 2015, https://doi.org/10.1016/j.livsci.2015.04.001